Adult AML Survivors Face Heightened Risk for Additional Cancers

Originally published by our sister publication Specialty Pharmacy ContinuumBy Cynthia E. KeenAdult acute myeloid leukemia (AML) survivors have a significantly higher risk of developing a second primary cancer in their lifetime compared with the general population, according to data presented at the 2026 ASCO Annual Meeting, in Chicago (abstract 11070). Adults younger than 59 years of age have the highest risk levels (standardized incidence ratio [SIR], 1.91), with higher measures in men (1.37) t